2018
DOI: 10.1007/s00280-018-3578-8
|View full text |Cite
|
Sign up to set email alerts
|

Cdc20/p55 mediates the resistance to docetaxel in castration-resistant prostate cancer in a Bim-dependent manner

Abstract: In conclusion, our data collectively demonstrated that Cdc20 overexpression facilitates the docetaxel resistant of the CRPC cell lines in a Bim-dependent manner. Furthermore, additionally targeting Cdc20 might be a promising solution for the treatment of the CRPC with docetaxel resistance.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
17
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 19 publications
2
17
0
Order By: Relevance
“…Of note, knockdown of CDC20 caused inhibition of growth, migration ability and formation of colonies in lung cancer cells, as well as cell cycle arrest in G2/M phase and induction of apoptosis ( 39 ), making this oncogene a potential target molecule to address NSCLC therapy. Upregulation of CDC20 has been associated with shorter OS in patients with LUAD, but not in patients with LUSC ( 40 ), which is consistent with the results of the present study.…”
Section: Discussionsupporting
confidence: 92%
“…Of note, knockdown of CDC20 caused inhibition of growth, migration ability and formation of colonies in lung cancer cells, as well as cell cycle arrest in G2/M phase and induction of apoptosis ( 39 ), making this oncogene a potential target molecule to address NSCLC therapy. Upregulation of CDC20 has been associated with shorter OS in patients with LUAD, but not in patients with LUSC ( 40 ), which is consistent with the results of the present study.…”
Section: Discussionsupporting
confidence: 92%
“…2b , top panel). CDC20 is part of the anaphase-promoting complex APC(CDC20), and recent reports corroborate synergistic effects with DCT in PCa 18 , 19 . We confirmed the knockdown capacity of the siRNAs by western blotting (Fig.…”
Section: Resultsmentioning
confidence: 71%
“…The potential of CDC20 as a therapeutic target for human cancer treatment has been reported in previous studies (22). Wu et al (23) investigated the effects of CDC20 overexpression in docetaxel-and castration-resistant prostate cancer cell lines, and demonstrated that CDC20 mediated resistance in a Bim-dependent manner. Paul et al (24) indicated that CDC20 regulated the proteasome-mediated degradation of the tumor suppressor BTG3 associated nuclear protein, and inhibited apoptosis in breast cancer cells.…”
Section: Discussionmentioning
confidence: 84%